Trial · NCT07912619
Comparison of Second- and Third-Generation Laryngeal Mask Airway in Pediatric Patients
NCT07912619, Not applicable, Not yet recruiting, Bursa Yuksek Ihtisas Training and Research Hospital
3 sourcestrials-2026-11-12-0.4.0
Cite this record
ConductScience Library. Comparison of Second- and Third-Generation Laryngeal Mask Airway in Pediatric Patients. Trials, record NCT07912619. Release trials-2026-11-12-0.4.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07912619
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Comparison of Second- and Third-Generation Laryngeal Mask Airway in Pediatric Patients
- NCT number
- NCT07912619
- Status
- Not yet recruiting
- Phases
- Not applicable
- Enrollment
- 90 participants, estimated
- Lead sponsor
- Bursa Yuksek Ihtisas Training and Research Hospital
- Conditions
- Airway Management, Anesthesia, General, Pediatric Anesthesia
- Interventions
- Second-Generation SafeLM LMA, Third-Generation SafeLM Video LMA
- First posted
- 2026-11-03
- Last updated
- 2026-11-03
Source ClinicalTrials.gov
Registered outcomes16
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Oropharyngeal Leak Pressure (OLP) | Measured immediately after device placement | Oropharyngeal leak pressure measured immediately after airway device placement, reflecting the sealing performance of the supraglottic airway. |
| Secondary | First-Attempt Success Rate | During device insertion (intraoperative) | Proportion of participants in whom the airway device was successfully placed on the first insertion attempt. |
| Secondary | Number of Insertion Attempts | During device insertion (intraoperative) | Total number of attempts required to successfully place the airway device. |
| Secondary | Glottic Exposure Grade (Video LMA group) | During device insertion (intraoperative) | Grade of glottic view (Grade 1-4) assessed via camera image in the video laryngeal mask group. |
| Secondary | Heart Rate | Before induction (T0), after device placement (T1), and during surgery (T2) | Heart rate (beats per minute) recorded before induction, after device placement, and during surgery. |
| Secondary | Systolic Blood Pressure | Before induction (T0), after device placement (T1), and during surgery (T2) | Systolic blood pressure (mmHg) recorded before induction, after device placement, and during surgery. |
| Secondary | Diastolic Blood Pressure | Before induction (T0), after device placement (T1), and during surgery (T2) | Diastolic blood pressure (mmHg) recorded before induction, after device placement, and during surgery. |
| Secondary | Peripheral Oxygen Saturation (SpO2) | Before induction (T0), after device placement (T1), and during surgery (T2) | Peripheral oxygen saturation (%) recorded before induction, after device placement, and during surgery. |
| Secondary | Intraoperative Complications | Intraoperative period | Incidence of laryngospasm, bronchospasm, desaturation (SpO2 \<90%), need for device repositioning, and need for conversion to endotracheal intubation. |
| Secondary | Postoperative Sore Throat, Hoarseness, and Nausea/Vomiting | Postoperative hour 1 (T3) and hour 6 (T4) | Presence or absence of sore throat, hoarseness, and nausea/vomiting assessed at 1 and 6 hours postoperatively. |
1 to 10 of 16Source ClinicalTrials.gov
See all 16 registered outcomesOutcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers4
The papers the trial lists on ClinicalTrials.gov.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Source
- Release
- trials-2026-11-12-0.4.0
- Release manifest SHA-256
- 0f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4
- Registry capture
- 2026-11-12
- Results copy, AACT
- 2026-03-23
- NIH clinical studies file
- 2026-11-13
Source ClinicalTrials.gov
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNone stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07912619
GET https://conductscience.org/api/trials/v1/NCT07912619/registered